Cargando…
Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
CONTEXT: Despite the wide revision of current guidelines, the management of papillary thyroid microcarcinoma (mPTC) still has to be decided case by case. There is conflicting evidence about the role of more frequent histological subtypes, and no data about potential differences at presentation. OBJE...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664971/ https://www.ncbi.nlm.nih.gov/pubmed/36397778 http://dx.doi.org/10.1210/jendso/bvac157 |
_version_ | 1784831200030883840 |
---|---|
author | Sparano, Clotilde Rotondi, Mario Verdiani, Valentina Brunori, Paolo Castiglione, Francesca Bartoli, Caterina Perigli, Giuliano Badii, Benedetta Vezzosi, Vania Simontacchi, Gabriele Livi, Lorenzo Antonuzzo, Lorenzo Maggi, Mario Petrone, Luisa |
author_facet | Sparano, Clotilde Rotondi, Mario Verdiani, Valentina Brunori, Paolo Castiglione, Francesca Bartoli, Caterina Perigli, Giuliano Badii, Benedetta Vezzosi, Vania Simontacchi, Gabriele Livi, Lorenzo Antonuzzo, Lorenzo Maggi, Mario Petrone, Luisa |
author_sort | Sparano, Clotilde |
collection | PubMed |
description | CONTEXT: Despite the wide revision of current guidelines, the management of papillary thyroid microcarcinoma (mPTC) still has to be decided case by case. There is conflicting evidence about the role of more frequent histological subtypes, and no data about potential differences at presentation. OBJECTIVE: Our aim was to compare the phenotype of the 2 most frequent mPTC variants, namely, classical papillary thyroid microcarcinoma (mPTCc) and the follicular variant of papillary thyroid microcarcinoma (mFVPTC) . METHODS: Retrospective observational study, from January 2008 to December 2017 of a consecutive series of patients with mPTCc and mFVPTC. All cases were classified according to the 2015 American Thyroid Association (ATA) risk classification. Clinical and preclinical features of mPTCc and mFVPTC at diagnosis were collected. The comparison was also performed according to the incidental/nonincidental diagnosis and differences were verified by binary logistic analysis. RESULTS: In total, 235 patients were eligible for the analysis (125 and 110 mPTCc and mFVPTC, respectively). Compared with mPTCc, mFVPTCs were more often incidental and significantly smaller (4 vs 7 mm) (P < .001 all), possibly influenced by the higher rate of incidental detection. mFVPTC and incidental (P < .001 both) tumors were significantly more often allocated within the low-risk class. A logistic regression model, with ATA risk class as the dependent variable, showed that both mFVPTC (OR 0.465 [0.235-0.922]; P = .028]) and incidental diagnosis (OR 0.074 [0.036-0.163]; P < .001) independently predicted ATA risk stratification. CONCLUSION: mFVPTC shows some differences in diagnostic presentation compared with mPTCc, and seems to retain a significant number of favorable features, including a prevalent onset as incidental diagnosis. |
format | Online Article Text |
id | pubmed-9664971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96649712022-11-16 Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size Sparano, Clotilde Rotondi, Mario Verdiani, Valentina Brunori, Paolo Castiglione, Francesca Bartoli, Caterina Perigli, Giuliano Badii, Benedetta Vezzosi, Vania Simontacchi, Gabriele Livi, Lorenzo Antonuzzo, Lorenzo Maggi, Mario Petrone, Luisa J Endocr Soc Clinical Research Article CONTEXT: Despite the wide revision of current guidelines, the management of papillary thyroid microcarcinoma (mPTC) still has to be decided case by case. There is conflicting evidence about the role of more frequent histological subtypes, and no data about potential differences at presentation. OBJECTIVE: Our aim was to compare the phenotype of the 2 most frequent mPTC variants, namely, classical papillary thyroid microcarcinoma (mPTCc) and the follicular variant of papillary thyroid microcarcinoma (mFVPTC) . METHODS: Retrospective observational study, from January 2008 to December 2017 of a consecutive series of patients with mPTCc and mFVPTC. All cases were classified according to the 2015 American Thyroid Association (ATA) risk classification. Clinical and preclinical features of mPTCc and mFVPTC at diagnosis were collected. The comparison was also performed according to the incidental/nonincidental diagnosis and differences were verified by binary logistic analysis. RESULTS: In total, 235 patients were eligible for the analysis (125 and 110 mPTCc and mFVPTC, respectively). Compared with mPTCc, mFVPTCs were more often incidental and significantly smaller (4 vs 7 mm) (P < .001 all), possibly influenced by the higher rate of incidental detection. mFVPTC and incidental (P < .001 both) tumors were significantly more often allocated within the low-risk class. A logistic regression model, with ATA risk class as the dependent variable, showed that both mFVPTC (OR 0.465 [0.235-0.922]; P = .028]) and incidental diagnosis (OR 0.074 [0.036-0.163]; P < .001) independently predicted ATA risk stratification. CONCLUSION: mFVPTC shows some differences in diagnostic presentation compared with mPTCc, and seems to retain a significant number of favorable features, including a prevalent onset as incidental diagnosis. Oxford University Press 2022-10-13 /pmc/articles/PMC9664971/ /pubmed/36397778 http://dx.doi.org/10.1210/jendso/bvac157 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Article Sparano, Clotilde Rotondi, Mario Verdiani, Valentina Brunori, Paolo Castiglione, Francesca Bartoli, Caterina Perigli, Giuliano Badii, Benedetta Vezzosi, Vania Simontacchi, Gabriele Livi, Lorenzo Antonuzzo, Lorenzo Maggi, Mario Petrone, Luisa Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size |
title | Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size |
title_full | Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size |
title_fullStr | Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size |
title_full_unstemmed | Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size |
title_short | Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size |
title_sort | classic and follicular variant of papillary thyroid microcarcinoma: 2 different phenotypes beyond tumor size |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664971/ https://www.ncbi.nlm.nih.gov/pubmed/36397778 http://dx.doi.org/10.1210/jendso/bvac157 |
work_keys_str_mv | AT sparanoclotilde classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT rotondimario classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT verdianivalentina classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT brunoripaolo classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT castiglionefrancesca classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT bartolicaterina classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT perigligiuliano classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT badiibenedetta classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT vezzosivania classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT simontacchigabriele classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT livilorenzo classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT antonuzzolorenzo classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT maggimario classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize AT petroneluisa classicandfollicularvariantofpapillarythyroidmicrocarcinoma2differentphenotypesbeyondtumorsize |